| |
| |
|
| Insider
Information: |
Braca John N |
| Relationship: |
Director |
| City: |
New Brunswick |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
152,979 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$111,170 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
152,979 |
|
|
| Total
Value |
$111,170 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eloxx Pharmaceuticals Inc |
ELOX |
Director |
2010-05-25 |
137,964 |
2005-05-19 |
0 |
Premium* |
|
|
Dataram Corp |
DRAM |
Director |
2020-11-02 |
15,015 |
2017-08-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DRAM |
Dataram Corp |
Director |
– • – |
2020-11-02 |
4 |
A |
$0.00 |
$0 |
D/D |
600 |
15,015 |
0 |
- |
|
| DRAM |
Dataram Corp |
Director |
– • – |
2020-09-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
14,415 |
0 |
- |
|
| DRAM |
Dataram Corp |
Director |
– • – |
2020-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
600 |
11,915 |
0 |
- |
|
| DRAM |
Dataram Corp |
Director |
– • – |
2020-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
600 |
11,315 |
0 |
- |
|
| DRAM |
Dataram Corp |
Director |
– • – |
2020-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
107,154 |
0 |
- |
|
| DRAM |
Dataram Corp |
Director |
– • – |
2019-09-18 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
101,154 |
0 |
- |
|
| DRAM |
Dataram Corp |
Director |
– • – |
2018-09-13 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
51,154 |
0 |
- |
|
| DRAM |
Dataram Corp |
Director |
– • – |
2017-08-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,154 |
1,154 |
0 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • – |
2010-05-25 |
4 |
OE |
$0.83 |
$64,607 |
D/D |
77,840 |
137,964 |
0 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • – |
2010-05-25 |
4 |
A |
$0.37 |
$2,038 |
D/D |
4,957 |
60,124 |
0 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • – |
2010-05-20 |
4 |
B |
$0.01 |
$20 |
D/D |
2,000 |
55,167 |
2.31 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • – |
2010-02-19 |
4 |
B |
$0.00 |
$0 |
D/D |
16,745 |
53,167 |
2.31 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • – |
2009-07-29 |
4 |
B |
$0.00 |
$0 |
D/D |
4,028 |
9,028 |
2.31 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • – |
2009-07-29 |
4 |
B |
$0.90 |
$2,000 |
D/D |
2,222 |
36,422 |
2.31 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • – |
2009-03-13 |
4 |
B |
$0.38 |
$2,954 |
D/D |
7,500 |
34,200 |
2.31 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • – |
2009-03-12 |
4 |
B |
$0.36 |
$1,377 |
D/D |
3,700 |
26,700 |
2.31 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • – |
2009-02-20 |
4 |
B |
$0.40 |
$2,075 |
D/D |
5,000 |
23,000 |
2.31 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • – |
2006-10-11 |
4 |
A |
$1.07 |
$10,700 |
D/D |
10,000 |
18,000 |
0 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • – |
2005-11-28 |
4 |
B |
$1.59 |
$7,950 |
D/D |
5,000 |
8,000 |
2.39 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • – |
2005-05-19 |
4 |
B |
$2.19 |
$6,570 |
D/D |
3,000 |
20,500 |
2.39 |
- |
|
20 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
